US Broker Ratings

Simulations Plus, Inc. (SLP) Stock Analysis: Navigating a 110% Potential Upside in Health Information Services

Simulations Plus, Inc. (SLP), a prominent player in the healthcare sector specializing in health information services, is capturing investor attention with its innovative suite of drug..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Navigating the 54.90% Revenue Growth Amid Analyst Skepticism

Avadel Pharmaceuticals plc (NASDAQ: AVDL) has captured investor attention with its impressive 54.90% revenue growth. As a biopharmaceutical company headquartered in Dublin, Ireland, Avadel focuses on..

Nutex Health Inc. (NUTX) Stock Analysis: Evaluating a 134% Potential Upside in the Healthcare Sector

Investors looking for opportunities in the healthcare sector might want to turn their attention to Nutex Health Inc. (NUTX), a company with a unique business model..

Akso Health Group (AHG) Stock Report: Navigating Challenges in the Medical Distribution Sector

Akso Health Group (NASDAQ: AHG), a key player in the medical distribution industry based in Qingdao, China, operates within the dynamic healthcare sector. With a market..

Weave Communications, Inc. (WEAV): Investor Outlook Highlights an 83% Potential Upside

Weave Communications, Inc. (NASDAQ: WEAV), a key player in the healthcare sector, specifically in health information services, has garnered significant attention from investors due to its..

LENZ Therapeutics (LENZ): Investor Outlook on a Biotech Stock with a 346% Potential Upside

For investors eyeing opportunities in the healthcare sector, LENZ Therapeutics, Inc. (NASDAQ: LENZ) stands out with its compelling potential upside of 346.35%. Specializing in biopharmaceutical innovations..

Nuvation Bio Inc. (NUVB) Stock Analysis: A 171% Potential Upside Awaits Investors

Nuvation Bio Inc. (NASDAQ: NUVB), a clinical-stage biopharmaceutical company based in New York, is making waves in the biotechnology sector. With a market capitalization of $1.48..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a 30% Potential Upside in the Biotech Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company based in Warminster, Pennsylvania, is making waves in the biotechnology sector. With a current market capitalization of..

Delcath Systems, Inc. (DCTH) Stock Analysis: Unveiling a Potential 128% Upside with Innovative Oncology Solutions

Delcath Systems, Inc. (NASDAQ: DCTH), an innovative player in the healthcare sector, is gaining attention for its promising advancements in interventional oncology. With a focus on..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Strong Revenue Growth and 179% Potential Upside Draw Investor Attention

Investors seeking opportunities in the healthcare sector might find Gyre Therapeutics, Inc. (NASDAQ: GYRE) an intriguing prospect. This biotechnology firm, with a market capitalization of $655.07..

Xeris Biopharma Holdings, Inc. (XERS): Investor Outlook on a Potential 99.69% Upside

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a commercial-stage biopharmaceutical company, is creating ripples in the healthcare sector with its innovative therapies targeting chronic endocrine and neurological..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Biotech Innovator with a 38% Potential Upside

Sionna Therapeutics, Inc. (SION) is capturing the attention of investors with its promising pipeline in the biotechnology sector, particularly in the treatment of cystic fibrosis (CF)...

CeriBell, Inc. (CBLL) Stock Analysis: A 46% Upside Potential Sparks Investor Interest

CeriBell, Inc. (NASDAQ: CBLL), a prominent player in the healthcare sector specializing in medical devices, is making waves in the investment community with its innovative approach..

Investor Outlook: Day One Biopharmaceuticals, Inc. (DAWN) – A Promising Biotech with a Robust Pipeline

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is making waves in the biotechnology sector with its strong commitment to addressing unmet medical needs in both pediatric and..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Unpacking a 37.39% Potential Upside Amid Biotech Innovations

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a burgeoning player in the biotechnology sector, is capturing investor attention with its innovative approach to cancer treatment and a notable..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: 48.3% Upside Potential and Strong Buy Ratings Signal Attention

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a notable player in the healthcare sector, is capturing investor attention with a substantial 48.3% potential upside, underpinned by strong buy..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Unveiling a 101% Potential Upside in the Biotech Sector

Nurix Therapeutics, Inc. (NASDAQ: NRIX), a pioneering entity in the biotechnology sector, is capturing investor attention with a staggering potential upside of 101.07%. Specializing in the..

uniQure N.V. (QURE) Stock Analysis: Exploring a Potential 151% Upside in Biotechnology

For investors with an eye on the biotechnology sector, uniQure N.V. (NASDAQ: QURE) presents a compelling opportunity, marked by its innovative approach in treating rare and..

AMN Healthcare Services Inc (AMN): Investor Outlook on a Promising 21.32% Upside

AMN Healthcare Services Inc (AMN), a pivotal player in the U.S. healthcare sector, offers a broad range of technology-enabled workforce solutions and staffing services. Serving various..

Beta Bionics, Inc. (BBNX) Stock Analysis: Exploring a 116.82% Potential Upside in the Medical Device Sector

Beta Bionics, Inc. (NASDAQ: BBNX), a pioneering force in the medical devices industry, is making waves with its innovative solutions to enhance the health and quality..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds